Target intelligence / Profile preview

Fungal microtubule

Molecular classification
Cytoskeletal protein, Tubulin polymer, Other
01

Overview

Fungal microtubules are dynamic cytoskeletal polymers composed primarily of α-tubulin and β-tubulin heterodimers that assemble into hollow tubes. They play essential roles in maintaining cell shape, enabling polarized tip growth in filamentous fungi, organizing the mitotic spindle during nuclear division, facilitating intracellular trafficking of vesicles and organelles, and supporting overall cellular architecture. In fungi specifically, the organization of these structures is coordinated by specialized organelles called spindle pole bodies—functionally analogous to centrosomes—which nucleate new microtubules via γ-tubulin complexes[1][5]. Disruption of fungal microtubules impairs critical processes such as hyphal extension and mitosis; thus they represent validated targets for several classes of antifungal drugs including benzimidazoles like benomyl and griseofulvin[6][7]. The main therapeutic challenge lies in achieving selectivity over mammalian counterparts due to structural conservation among eukaryotic tubulins.

Other names
Microtubules (in fungi)fungal cytoskeletal microtubulefungal tubulin polymerspindle microtubule (fungal)
02

Mechanism of action

Drugs targeting fungal microtubules typically act by binding to tubulin subunits, inhibiting their polymerization or destabilizing existing microtubules. This disrupts mitotic spindle formation, nuclear division, intracellular transport, and ultimately inhibits cell proliferation or causes cell death[7].

03

Biological functions

Cell division (mitosis and meiosis)Intracellular transportCell shape maintenancePolarized cell growth/tip growth in hyphaeNuclear movement and positioning[2][6][7][8]
04

Disease associations

Infection (as a target for antifungal therapy)[7]Other (essential for fungal viability and pathogenesis)
05

Safety considerations

Microtubule-targeting drugs may have off-target effects on host cells due to the conserved nature of tubulin across eukaryotes. Selectivity for fungal versus mammalian tubulin is a key therapeutic challenge. Resistance can also develop through mutations in tubulin genes or altered drug uptake/efflux[7].
06

Interacting drugs

Benomyl

2 more in the full profile.

Beyond the preview

Go deeper on Fungal microtubule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Fungal microtubule.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call